Macrogenics (MGNX) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts MGNX Hot Sheet
Join SI Premium – FREE
Macrogenics (NASDAQ: MGNX) reported Q1 EPS of ($0.65), in-line with the analyst estimate of ($0.65). Revenue for the quarter came in at $13.19 million versus the consensus estimate of $14.06 million.
For earnings history and earnings-related data on Macrogenics (MGNX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MacroGenics to receive $24.5M milestone from Sanofi on FDA approval
- Rocket Lab launches U.S. Space Force mission in record 16 hours
- A. O. Smith CEO Stephen Shafer named chairman
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
